Approval · Notice of Compliance 17251 · 2015
CONTINGENCY: Notice of Compliance 17251
Issued September 2, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17251
- Date
- September 2, 2015
- Company
- Jai Pharma LimitedMumbai, Maharashtra, India
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Canadian reference product
- PLAN B
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CONTINGENCY | 02410230 | Cancelled Pre Market |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB